Denali Therapeutics to report third-quarter financial results

DNLI•2026-10-22

Denali Therapeutics will report third-quarter 2026 financial results and business highlights on Nov. 3, 2026, and hold a conference call and webcast at 4:30 p.m. Eastern.

1. Results announcement

Denali Therapeutics will report third-quarter 2026 financial results and business highlights on Nov. 3, 2026. Management will host a conference call and webcast at 4:30 p.m. Eastern to discuss the results and provide a business update.

Denali Therapeutics to report third-quarter financial results

1. Results announcement

Related News

Midland States Bancorp Q3 EPS beats estimates on loan growth, improved credit

Oakworth Capital Q3 net income rises on loan and wealth-management growth

Aurelion agrees to $2 million private share placement with Antalpha Capital

Sangrix sells 75,000 Class B shares to CEO in $32,925 private placement

Fitch expects smaller US mortgage market in 2027 to limit earnings upside